Compugen (CGEN) Total Liabilities (2009 - 2026)
Compugen (CGEN) posted quarterly Total Liabilities of $145.9 million for Q1 2026, up 26.35% year-over-year from $115.4 million in Q1 2025, and down 6.84% on a QoQ basis from $156.6 million in Q4 2025.
Analysis
Compugen (CGEN) Total Liabilities (2009 - 2026) Analysis & Trends
Compugen has reported Total Liabilities for 18 years, with the latest figure at $145.9 million in Q1 2026.
- Total Liabilities for Q1 2026 came in at $145.9 million, up 26.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $145.9 million (up 26.35% YoY), and the FY2025 annual result was $156.6 million, up 36.15% from the prior year.
- Total Liabilities slipped to $145.9 million in Q1 2026, from $156.6 million in the prior quarter.
- Over five years, Total Liabilities peaked at $156.6 million in Q4 2025 and troughed at $67.6 million in Q3 2023.
- A 5-year average of $109.4 million and a median of $110.3 million in 2022 frame the typical range for Total Liabilities.
- The widest annual swing landed in 2023, when Total Liabilities slumped 31.96%; it then jumped 82.69% in 2024.
- A 5-year view of Total Liabilities shows it stood at $94.2 million in 2022, then advanced by 28.84% to $121.3 million in 2023, then slipped by 5.22% to $115.0 million in 2024, then surged by 36.15% to $156.6 million in 2025, then decreased by 6.84% to $145.9 million in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $145.9 million in Q1 2026, $156.6 million in Q4 2025, and $97.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4.20 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 1.72 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 4.00 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 10.03 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 | 49.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.63 Mn |
| Mar 31, 2026 | 50.51 Mn |
| Dec 31, 2025 | 53.84 Mn |
| Sep 30, 2025 | 54.02 Mn |
| Jun 30, 2025 | 56.27 Mn |
| Mar 31, 2025 | 58.34 Mn |
| Dec 31, 2024 | 60.08 Mn |
| Sep 30, 2024 | 63.03 Mn |
| Jun 30, 2024 | 51.83 Mn |
| Mar 31, 2024 | 54.03 Mn |
| Dec 31, 2023 | 55.78 Mn |
| Sep 30, 2023 | 14.38 Mn |
| Jun 30, 2023 | 15.05 Mn |
| Mar 31, 2023 | 15.11 Mn |
| Dec 31, 2022 | 16.50 Mn |
| Sep 30, 2022 | 19.55 Mn |
| Jun 30, 2022 | 19.93 Mn |
| Mar 31, 2022 | 22.78 Mn |
| Dec 31, 2021 | 25.47 Mn |
| Sep 30, 2021 | 22.47 Mn |